|
1.
|
Brodeur GM: Neuroblastoma: biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Maris JM: Recent advances in
neuroblastoma. N Engl J Med. 362:2202–2211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Maris JM: The biologic basis for
neuroblastoma heterogeneity and risk stratification. Curr Opin
Pediatr. 17:7–13. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: new insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Moll R, Franke WW, Schiller DL, Geiger B
and Krepler R: The catalog of human cytokeratins: patterns of
expression in normal epithelia, tumors and cultured cells. Cell.
31:11–24. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Carén H, Djos A, Nethander M, Sjöberg RM,
Kogner P, Enström C, Nilsson S and Martinsson T: Identification of
epigenetically regulated genes that predict patient outcome in
neuroblastoma. BMC Cancer. 11:662011.PubMed/NCBI
|
|
11.
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Karreth F and Tuveson DA: Twist induces an
epithelial-mesenchymal transition to facilitate tumor metastasis.
Cancer Biol Ther. 3:1058–1059. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Valsesia-Wittmann S, Magdeleine M,
Dupasquier S, Garin E, Jallas AC, Combaret V, Krause A, Leissner P
and Puisieux A: Oncogenic cooperation between H-Twist and N-Myc
overrides failsafe programs in cancer cells. Cancer Cell.
6:625–630. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Puisieux A, Valsesia-Wittmann S and
Ansieau S: A twist for survival and cancer progression. Br J
Cancer. 94:13–17. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Perez-Moreno MA, Locascio A, Rodrigo I,
Dhondt G, Portillo F, Nieto MA and Cano A: A new role for E12/E47
in the repression of E-cadherin expression and
epithelial-mesenchymal transitions. J Biol Chem. 276:27424–27431.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Ho R, Minturn JE, Hishiki T, Zhao H, Wang
Q, Cnaan A, Maris J, Evans AE and Brodeur GM: Proliferation of
human neuroblastomas mediated by the epidermal growth factor
receptor. Cancer Res. 65:9868–9875. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Tamura S, Hosoi H, Kuwahara Y, Kikuchi K,
Otabe O, Izumi M, Tsuchiya K, Iehara T, Gotoh T and Sugimoto T:
Induction of apoptosis by an inhibitor of EGFR in neuroblastoma
cells. Biochem Biophys Res Commun. 358:226–232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Chiu B, Mirkin B and Madonna MB: Epidermal
growth factor can induce apoptosis in neuroblastoma. J Pediatr
Surg. 42:482–488. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Chiu B, Mirkin B and Madonna MB: Mitogenic
and apoptotic actions of epidermal growth factor on neuroblastoma
cells are concentration-dependent. J Surg Res. 135:209–212. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Chiu B, Mirkin B and Madonna MB: Novel
action of epidermal growth factor on caspase 3 and its potential as
a chemotherapeutic adjunct for neuroblastoma. J Pediatr Surg.
42:1389–1395. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Richards KN, Zweidler-McKay PA, Van Roy N,
Speleman F, Trevino J, Zage PE and Hughes DP: Signaling of ERBB
receptor tyrosine kinases promotes neuroblastoma growth in vitro
and in vivo. Cancer. 116:3233–3243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Gambini C, Sementa AR, Boni L, Marino CE,
Croce M, Negri F, Pistoia V, Ferrini S and Corrias MV: Expression
of HER2/neu is uncommon in human neuroblastic tumors and is
unrelated to tumor progression. Cancer Immunol Immunother.
52:116–120. 2003.PubMed/NCBI
|
|
23.
|
Izycka-Swieszewska E, Wozniak A, Drozynska
E, Kot J, Grajkowska W, Klepacka T, Perek D, Koltan S, Bien E and
Limon J: Expression and significance of HER family receptors in
neuroblastic tumors. Clin Exp Metastasis. 28:271–282. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Sithanandam G and Anderson LM: The ERBB3
receptor in cancer and cancer gene therapy. Cancer Gene Therapy.
15:413–448. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Gullick WJ: The c-erbB3/HER3 receptor in
human cancer. Cancer Surv. 27:339–349. 1996.PubMed/NCBI
|
|
26.
|
Travis A, Pinder SE, Robertson JF, Bell
JA, Wencyk P, Gullick WJ, Nicholson RI, Poller DN, Blamey RW,
Elston CW and Ellis IO: C-erbB-3 in human breast carcinoma:
expression and relation to prognosis and established prognostic
indicators. Br J Cancer. 74:229–233. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Sergina NV, Rausch M, Wang D, Blair J,
Hann B, Shokat KM and Moasser MM: Escape from HER-family tyrosine
kinase inhibitor therapy by the kinase-inactive HER3. Nature.
445:437–441. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Baselga J and Swain SM: Novel anticancer
targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer.
9:463–475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Fuchs BC, Fujii T, Dorfman JD, Goodwin JM,
Zhu AX, Lanuti M and Tanabe KK: Epithelial-to-mesenchymal
transition and integrin-linked kinase mediate sensitivity to
epidermal growth factor receptor inhibition in human hepatoma
cells. Cancer Res. 68:2391–2399. 2008. View Article : Google Scholar
|
|
30.
|
Thomson S, Petti F, Sujka-Kwok I, Epstein
D and Haley JD: Kinase switching in mesenchymal-like non-small cell
lung cancer lines contributes to EGFR inhibitor resistance through
pathway redundancy. Clin Exp Metastasis. 25:843–854. 2008.
View Article : Google Scholar : PubMed/NCBI
|
